RAB32 and non-small cell lung carcinoma: We also observed a diagnostic potential of RAB32 and THBS1 by profiling their RNA expression from exosomes extracted from longitudinally sampled plasma of EGFR-mutation-positive NSCLC patients treated with osimertinib.